BayBio Members

Abbott
http://www.abbott.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Contract Manufacturing
Medical Devices
Therapeutic

Accenture
560 Mission Street
San Francisco, CA, United States, 94105
415-537-5000
http://www.accenture.com/Primary Contacts
Bill Annett
Partner, West Coast Life Sciences
415-537-4613
Company Profile
Accenture™'s Life Sciences practice works with pharmaceuticals, biotechnology, medical products, medical technology, regulators, distributors, wholesalers and other companies to help bring life-enhancing health solutions to people around the globe. Accenture provides consulting, technology and outsourcing services across the entire life sciences value chain, from large-scale business and technology transformation to post-merger integration. Key offerings include: Research and Development, including pharmacovigilance and regulatory outsourcing; Supply Chain and Manufacturing Optimization; and Marketing and Sales, including commercial services, analytics and digital marketing. With more than 10,000 professionals dedicated to life sciences working in more than 50 countries, Accenture helps companies overcome industry challenges, achieve business objectives and drive sustainable growth.Company Classification
Associate/Service ProvidersOrganization Type
Consulting Firms

Alexandria Real Estate Equities, Inc.
1700 Owens Street, Suite 590
San Francisco, CA, 94158
415-554-8844
http://www.labspace.comPrimary Contacts
Stephen Richardson
Executive Vice President - Regional Market Director
Company Profile
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest REIT focused principally on providing high-quality real estate for the life science industry. Since 1994, Alexandria has created first-in-class life science clusters that foster innovative and collaborative environments in key locations immediately proximate to leading research institutions. Alexandria’s broad and diverse tenant base includes internationally renowned academic and medical institutions, multinational pharmaceutical companies, leading private and public biotechnology entities, non-profit institutions, government agencies, medical device companies, biofuels companies, research tools and service companies, and venture capitalists. Located in the top life science markets around the globe, Alexandria’s world-class properties, highly specialized operations, and expansive network assist the life science industry in translating promising discoveries into important, safe, and effective products that benefit humankind.Company Classification
Associate/Service ProvidersOrganization Type
Real Estate

Amgen Inc.
1120 Veteran's Blvd
South San Francisco, CA, 94080
650-244-1000
http://www.amgen.com/Primary Contacts
Dr. Terry Rosen
Vice President, Research; ASF Site Head
Company Profile
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug Development
TherapeuticClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Barney & Barney LLC
1999 Harrision Street, Suite 1230
Oakland, CA, United States, 94612
510-273-8888
http://www.barneyandbarney.comPrimary Contacts
Kevin Mirsky
Principal, Tech & Life Science Practice
510 466 6058
Company Profile
Barney & Barney is one of the largest insurance brokerage firms in the United States. Barney & Barney provides clients with commerical insuance and employee benefit brokerage services, risk management, personal insurance, wealth management and compensation consulting. The firm's largest concentration of clients is within its Technology & Life Science Practice Group.Company Classification
Associate/Service ProvidersOrganization Type
Insurance

Baxter Healthcare Corporation
One Baxter Drive
Deerfield, IL, 60015
847.948.2000
http://www.baxter.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Contract Manufacturing
Medical Devices
TherapeuticClinical Development Stage
Phase I
Phase II
Phase III
Approved

Bayer Healthcare
800 Dwight Way
Berkeley, CA, 94710
510-705-5000
http://www.biotech.bayerhealthcare.comPrimary Contacts
Joerg Heidrich
Sr. Vice President, Product Supply Biotech
Olivia Krampe
Vice President and Site Head, Emeryville Supply Center
Terry Hermiston
Vice President, US Biologics Research; Head, U.S. Innovation Center
Company Profile
Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world’s leading, innovative companies in the healthcare and medical products industry. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2010) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Cardiovascular & Circulatory Disorders
Central Nervous
Dermatology
Genetic Diseases
Kidneys & Genito-Urinary System
Ophthalmology
Respiratory Disorders
Womens HealthPrimary Technology
Biomanufacturing
Drug DiscoveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

BioMed Realty Trust
7677 Gateway Blvd. Suite 100
Newark, CA, 94560
510-505-6064
http://www.biomedrealty.comPrimary Contacts
Luyen Pham
Associate
510-505-6064
Scott Altick
Associate
510-505-6044
Anne Hoffman
Senior Vice President, Development
510 505 6046
Company Profile
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. We acquire, develop, own and operate laboratory and office space. Our properties are designed to effectively support the demanding needs of a wide range of pharmaceutical, biotechnology and research institutions. We currently own or have interests in 85 properties, which comprise 147 buildings with approximately 12.2 million rentable square feet.Company Classification
Associate/Service ProvidersOrganization Type
Real Estate

BioSpace
6465 South Greenwood Plaza Blvd.
Centennial, CO, United States, 80111
888.BIOSPACE
http://www.biospace.comPrimary Contacts
Sahar Azarabadi
Director of Sales
415-775-1141
Joe Kroog
Director, Product Management
303-562-0351
June Salvati
Director, Career Fairs
(732-746-2296
Valerie Quintanilla
Senior Manager, Marketing Communications
303-562-0144
Company Profile
BioSpace (www.biospace.com) is the leading online community for life science careers, news and other resources. For more than two decades, BioSpace has helped accelerate recruitment, communication and discovery among business and scientific leaders in the biopharmaceutical market. BioSpace hosts more than 20 biopharmaceutical career events every year across the U.S. and has over 1,500 life science companies looking for talented professionals online. Job Seekers can create a free profile, set up automatic job alerts, post their resume, search & apply to life sciences jobs and subscribe to FREE BioSpace eNewsletters. An onTargetjobs, Inc., company, BioSpace.com powers DeviceSpace.com (www.devicespace.com) as a portal for medical device and diagnostics industries, ClinicaSpace.com (www.clinicaspace.com) for clinical research professionals and BioSpace Collaborative for those in academic and biomedical research (www.biospace.com/collaborative).Company Classification
Associate/Service ProvidersOrganization Type
Corporate Communication
MediaClinical Development Stage
Phase I

Burr Pilger Mayer, Inc.
2000 University Ave, Suite 201
East Palo Alto, CA, United States, 94303
415-421-5757
http://www.bpmcpa.comPrimary Contacts
Michael Benjamin
Partner
415-288-6294
Company Profile
Burr Pilger Mayer (BPM) is the largest California-based accounting and consulting firm. We’ve been serving the Bay Area’s emerging and mid-cap businesses as well as high net worth individuals for 25 years.Company Classification
Associate/Service ProvidersOrganization Type
Accounting Firms

Burrill & Company
One Embarcadero Center, Suite 2700
San Francisco, CA, 94111
415 591 5400
http://www.burrillandco.comPrimary Contacts
G. Steven Burrill
CEO
415 591 5404
Roger Wyse
Managing Director
415 591 5416
Ann Hanham
Managing Director
415 591 5429
Bryant Fong
Managing Director
415 591 5412
John Hamer
Managing Director
415 591 5432
Company Profile
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the Life Sciences industry. With more than $1 billion in assets under management, the firm's businesses include venture capital, private equity, merchant banking and media. This unique combination of resources and capabilities enables us to provide Life Sciences companies with capital, management expertise, industry insight, market intelligence and analysis through its investments, conferences and publications. Headquartered in San Francisco, Burrill & Company oversees a global network of offices throughout the United States, Latin America, Europe and Asia.Company Classification
Associate/Service ProvidersOrganization Type
Venture Capital

CBS5
United States, http://sanfrancisco.cbslocal.com/Company Classification
Associate/Service ProvidersOrganization Type
Corporate Communication
Media

Cooley Godward Kronish LLP
United States, http://www.cooley.comCompany Classification
Associate/Service ProvidersOrganization Type
Law Firms

Corning Axygen
United States, http://www.corning.com/lifesciences/us_canada/en/index.aspxCompany Classification
Associate/Service Providers

Deloitte & Touche
555 Mission Street
San Francisco, CA, 94105
415-783-4000
http://www.us.deloitte.comPrimary Contacts
Keith Donnermeyer
Partner, U.S. Life Sciences Industry Leader, Audit & Enterprise Risk Services
415-783-5554
Cathy Coste
Partner, Life Sciences - Enterprise Risk Services
415-783-4357
Matthew Hudes
U.S. Managing Principal, Biotechnology
415-783-6161
Christie Smith, PhD
Principal, West Region Life Science Industry Leader
1-646-785-6711
Michael Vanderklugt
Partner, Life Sciences - Audit Services
415-783-4517
Alfonse Upshaw
Partner, Life Sciences - Audit Services
415-783-6280
Company Profile
Deloitte’s Life Sciences practice brings fresh ideas and groundbreaking concepts to clients and industry leaders alike. Whether it’s market innovations in biotechnology or providing exceptional counsel to some of the world's leading pharmaceutical and medical device companies, Deloitte offers a distinctive menu of professional services delivered in an integrated, collaborative approach that cuts across all segments of the Life Science industry - pharmaceuticals, biotechnology, medical products and technology and medical devices. We work in four key business areas — audit, financial advisory, tax and consulting — but our real strength comes from combining the talents of those groups to address clients’ needs. Deloitte is one of the largest private professional services network in the world with approximately 170,000 professionals in more than 140 countries. In the United States, Deloitte LLP and its subsidiaries have more than 45,000 professionals with a single focus: serving our clients and helping them solve their toughest problems. Our clients demand top value and unbending commitment from us. We demand nothing less of ourselves in working to become their trusted business advisors.Company Classification
Associate/Service ProvidersOrganization Type
Accounting Firms

DLA Piper US LLP
555 Mission Street, Suite 2400
San Francisco, CA, United States, 94105
415.836.2530
http://www.dlapiper.comPrimary Contacts
Bruce W. Jenett
Partner
650.833.2321
Lisa Haile
Partner
858.677.1456
Company Profile
DLA Piper has 3,500 lawyers in offices throughout Asia-Pacific, Europe, the Middle East and the United States. In the US alone, we have 1,500 lawyers in more than 20 cities, including top business and technology markets across the country. We represent more clients in a broader range of geographies and practice disciplines than virtually any other law firm in the world. Our client commitment is also our brand – everything matters when it comes to the way we serve and interact with our clients. If it matters to them, it matters to us. DLA Piper was built to serve clients wherever in the world they do business - quickly, efficiently and with genuine knowledge of both local and international considerations. But while markets around the world are internationalizing, this doesn’t mean they are becoming the same. We remain committed, as always, to the local markets that are the building blocks of international business.Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Drinker Biddle
United States, http://www.dbr.com/Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Elan Pharmaceuticals, Inc.
800 Gateway Blvd
South San Francisco, CA, 94080
(650) 877-7647
http://www.elan.comPrimary Contacts
Kelly Martin
Chief Executive Officer
Company Profile
Elan is a neuroscience-based biotechnology company,Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Central NervousPrimary Technology
Cell Biology
Drug DiscoveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Ernst & Young LLP
United States, http://www.ey.comCompany Classification
Associate/Service ProvidersOrganization Type
Accounting Firms
Financial Services

Fenwick and West, LLP
801 California Street
Mountain View, CA, 94041
650.988.8500
http://fenwick.comPrimary Contacts
Stephen M. Graham
Co-Chair, Life Sciences Group; Partner, Corporate Group
206.389.4520
Michael J. Shuster, Ph.D.
Co-Chair, Life Sciences Group; Partner, Intellectual Property Group
415.875.2413
Gordon K. Davidson
Firm Chairman; Partner, Corporate Group
Lynn H. Pasahow
Partner, Litigation Group
650.335.7225
Robert A. Kahn
Director of Business Development
650.335.7616
Tory B. Duffy
Marketing and Recruiting Coordinator
206.389.4589
Company Profile
Fenwick & West's Life Sciences Industry Group consists of more than 60 attorneys and scientists—including more than 15 with Ph.D.s—who provide a broad mix of core legal services to private companies, public companies, investors and research institutions. Many of our Life Sciences Group attorneys have scientific and research experience prior to their legal careers, and a number have advanced technical degrees in disciplines such as molecular biology, organic chemistry, electrical engineering, and immunology. For more information, visit www.fenwick.com/lifesciences.Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Genencor International
United States, http://www.genencor.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioFuels
Industrial Biotechnology

Genentech
1 DNA Way
South San Francisco, CA, 415-650-2000
http://www.gene.comPrimary Contacts
Ian Clark
CEO
Company Profile
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. In March 2009, Genentech became a member of the Roche Group. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Cancer
Cardiovascular & Circulatory Disorders
Ophthalmology
Respiratory DisordersPrimary Technology
Biomanufacturing
Drug DiscoveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA, 94404
650 574 3000 or 800
http://www.gilead.comPrimary Contacts
John C. Martin, PhD
Chairman and Chief Executive Officer
John F. Milligan, PhD
President and Chief Operating Officer
Gregg H. Alton
Executive Vice President, Corporate and Medical Affairs
Company Profile
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Cancer
Cardiovascular & Circulatory Disorders
Infectious Disease
Respiratory DisordersPrimary Technology
Drug DiscoveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

King & Spalding LLP
United States, http://www.kslaw.comCompany Classification
Associate/Service ProvidersOrganization Type
Law Firms

KPMG
55 Second St, Suite 1400
San Francisco, CA, 94105
415-963-0100
http://wwww.kpmg.comPrimary Contacts
Paulette DeFalco
West Area Life Sciences Leader
415-963-7345
Chris Cimino
Advisory Partner- Life Sciences
415-963-5451
Company Profile
KPMG is a global professional services firm specializing in providing audit, tax and advisory services to small, middle market and global life science companiesCompany Classification
Associate/Service ProvidersOrganization Type
Accounting Firms

Latham & Watkins
140 Scott Dr.
Menlo Park, CA, 94025
650-328-4600
http://www.lw.comPrimary Contacts
Alan Mendelson
Partner
650.328.4600
Mark Roeder
Partner
650.328.4600
Judith Hasko
Partner
650.328.4600
Chuck Hoyng
Partner
650.328.4600
Cory Cullen
Business Development Manager
650.328.4600
Peter Boyd
Associate
650.328.4600
Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Merrill DataSite
United States, http://www.datasite.com/Company Classification
Associate/Service ProvidersOrganization Type
Information Technology

Morrison & Foerster LLP
United States, http://www.mofo.com/Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Nektar Therapeutics
http://www.nektar.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

Novartis Diagnostics
4560 Horton St.
Emeryville, CA, 94608
http://www.novartis.comPrimary Contacts
Peter Maag
President, Novartis Diagnostics, Emeryville Site Head
Company Profile
Novartis provides healthcare solutions that address the evolving needs of patients and societies. In Emeryville, CA, Novartis has two divisions, Novartis Diagnostics and Novartis Institutes for BioMedical Research (NIBR). Novartis Diagnostics is the established global leader in blood safety, a position built on more than 20 years of scientific excellence, ongoing innovation, and collaboration with our development partners. Worldwide, more of the 93 million units of donated blood are tested with Novartis' blood screening products than any other NAT system. Building on its strong presence in transfusion medicine, Novartis Diagnostics is moving into new diagnostic areas, creating innovative tests to detect, prevent and predict disease and to improve medical outcomes. Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis committed to discovering innovative medicines that treat disease and improve human health. At NIBR Emeryville, the Oncology and Infectious Disease teams cover a broad spectrum of expertise including signal transduction pathways, cell cycle control, pharmacology, biologics research, structural biology and medicinal and computational chemistry.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Diagnostic

Onyx Pharmaceuticals, Inc.
249 East Grand Avenue
South San Francisco, CA, 94080
650.266.0000
http://www.onyx-pharm.com/Primary Contacts
N. Anthony Coles, M.D.
President and CEO
Laura A. Brege
Executive Vice President, Corporate Affairs
Matthew K. Fust
Executive Vice President and Chief Financial Officer
Company Profile
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, an alpha-folate receptor targeted inhibitor of the thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
CancerClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Pfizer Inc./Rinat
230 E. Grand Ave.
South San Francisco, CA, 94080
650-615-7300
http://www.pfizer.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug Development

PwC
3 Embarcadero Center
San Francisco, CA, 94111
415.498.5000
http://www.pwcglobal.com/Primary Contacts
Lisa Gaston
Geography Marketing Manager
415-498-5389
Peter Claude
Northern California, Pharmaceutical/Life Sciences Sector Leader
415.498.5024
Tracy Lefteroff
National Life Sciences Partner
408.817.4176
John Sichak
Pharmaceutical/Life Sciences Assurance Partner
408.817.3930
Company Profile
PwC firms provide industry-focused assurance, tax and advisory services to enhance value for their clients. More than 161,000 people in 154 countries in firms across the PwC network share their thinking, experience and solutions to develop fresh perspectives and practical advice.Company Classification
Associate/Service Providers

RoseRyan
United States, http://www.roseryan.comCompany Classification
Associate/Service ProvidersOrganization Type
Accounting Firms

Salter Group
1840 Century Park East, Suite 400
Los Angeles, CA, United States, http://www.saltergroup.comPrimary Contacts
Sam Renwick
Managing Director
925-942-0373
Company Profile
Salter Group is a leading financial and strategic advisory firm specializing in providing independent forecasting services, valuations, financial opinions, financial and strategic advisory services and transaction support. Since our formation in 2003, Salter Group has completed over 400 life sciences and health care engagements representing over $10 billion in asset and transaction values. Salter Group cost-effectively offers a unique perspective for the development of forecasts, valuations and advisory services by combining the analytical and modeling rigor of a capital markets constituent with a robust data-intensive primary and secondary research capability that spans 100,000’s of thought leaders, care providers, payors and other experts through our partners. Rather than relying on a significant up-front fee regardless of whether a transaction closes (the model for many consulting firms), we have the flexibility to earn our fees in a different fashion, charging less up front but earning a fee if a transaction is successfully completed. The end result is a cost-effective integrated research and model solution that can help your company be better prepared in your discussions with licensing partners, investors, lenders or acquirers.Organization Type
Financial Services

Squire Sanders
275 Battery Street
San Francisco, CA, United States, 94121
415-954-0358
http://www.ssd.comPrimary Contacts
Maureen Bennett
maureen.bennett@squiresaunders.com
Cameron Kerrigan
cameron.kerrigan@squiresanders.com
Rahul Pathak
rahul.pathak@squiresanders.com
Beth Seals
beth.seals@squiresanders.com
Phil Zender
philip.zeder@squiresanders.com
Company Profile
A global legal practice, Squire Sanders combines sound legal counsel with a deep knowledge of our clients’ businesses to resolve their legal challenges. We care about the quality of our services, the success of our clients and the relationships that are forged through those successes. Our lawyers have an in-depth understanding of the life sciences industry, gained through their representation of clients in life sciences and interrelated sectors such as: Bioengineering Biomedical Biotechnology Pharmaceuticals Medical devices We offer a full range of life sciences services: Competition law Consumer protection Intellectual property rights protection International trade Leveraged buyouts Licensing Litigation and arbitration Manufacturing and distribution Marketing practices Mergers, acquisitions and joint ventures Patent and technology licensing Private placements of securities Product liability Public offerings Recapitalization Taxation Technology transfer Venture capital investmentsCompany Classification
Associate/Service ProvidersOrganization Type
Law Firms

Technology Vision Group
United States, http://www.techvision.comCompany Classification
Associate/Service Providers

Thermo Fisher Scientific
81 Wyman Street
Waltham, United States, MA
781-622-1000
http://www.thermofisher.comPrimary Contacts
Michael J. Brown
Vice President, Business Development
(508) 963-3168
Andrew Setikas
Strategic Account Director
(707) 547-7223
Company Profile
Thermo Fisher Scientific offers BayBio members access to technology and expertise for every step in bioproduction - from research and development through scale up. With a mission to enable our customers to make the world healthier, cleaner, and safer Thermo Fisher Scientific provides an unmatched breadth and depth of capabilities, including: • Analytical, Environmental and Process instrument solutions enabled by world-class software • Bioprocess production technologies • Financial Services solutions • Clinical Trial Services and Supply Chain Integration • Biological Off-Site Storage and Logistics • Educational programs and technology forums With revenues of more than $11 billion and approximately 37,000 employees, Thermo Fisher Scientific is the world leader in serving science serving customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.Company Classification
Associate/Service ProvidersOrganization Type
BioTool
Consulting Firms

VWR International, LLC
3745 Bayshore Blvd
Brisbane, CA, United States, 94005
800-932-5000
http://www.vwr.comPrimary Contacts
Kareem Dossa
Vice President - West
415-570-0740
Joe Pellegrino
Region Manager
415-570-0738
Don Brennan
Region Manager
408-307-0084
Kalei Hampson
Region Manager
707-293-7505
Michael Guerra
Business Development Director
408-888-0021
Kim Brocchini
Region Manager
916-397-7324
Company Profile
VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $3.6 billion in 2010. VWR enables the advancement of the world’s most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 7,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services. For more information on VWR please visit www.vwr.com.Company Classification
Associate/Service ProvidersOrganization Type
Consulting Firms

Wareham Development
1120 Nye Street, Suite 400
San Rafael, CA, 94901
415-457-4964
http://www.warehamproperties.comPrimary Contacts
Chris Barlow
Partner
415-457-4964
Geoffrey B. Sears
Partner
415-457-4964
James Goddard
Partner
045-457-4964
Judith Wetterer
Communications Director
415-457-4964
Company Profile
Over the years, Wareham Development has earned a stellar reputation as a developer, owner and landlord for companies in the life sciences, film production, and other industries requiring complex technology infrastructures. Investing the up-front capital to meet today’s needs, Wareham Development creates spaces that adapt to tomorrow’s vision. The Wareham approach is to foster mutually beneficial long-term relationships with their tenants. As a privately-held company with a dedicated team of professionals on its staff, Wareham Development prides itself on the ability to be agile and decisive. Their principals are personally involved in every project, crafting creative leases to support business growth and managing buildings to ensure ongoing efficiency. Above all, Wareham Development believes in the future promise of its tenants, whether it’s a start-up sparked by a brilliant idea, or a major corporation building on past successesCompany Classification
Associate/Service ProvidersOrganization Type
Real Estate

Wells Fargo Insurance Services Inc.
959 Skyway Road, Suite 200
San Carlos, CA, United States, 94070
650.413.4200
http://www.wellsfargo.comPrimary Contacts
Peter B. Daly
Senior Vice President
650.413.4213
Company Classification
Associate/Service ProvidersOrganization Type
Financial Services
Insurance

17th Street Legal, PLLC
1714 n. McCadden Pl. #2404
Los Angeles, CA, United States, 90028
301-520-9950
http://www.17thstreetlegal.comPrimary Contacts
Holly Logue
Founder
Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

3-V Biosciences, Inc.
1050 Hamilton Court
Menlo Park, CA, United States, 94025
650-561-8690
http://www.3vbio.com/Primary Contacts
Merdad Parsey
Chief Executive Officer
Stephen Brady
Chief Business Officer
Robert McDowell
Vice President Research
Company Profile
The company is initially focused on treating respiratory illnesses, and its strategy is readily applicable to other types of infections. 3-V Biosciences uses small interfering RNA (siRNA) to identify host targets required for successful viral replication. Small molecule inhibitors of these host targets are used to confirm antiviral activity while also assessing potential cell toxicity. Using this integrated approach, the company has discovered a number of targets and related host pathways required for viral infection. The lead program's small molecule inhibitor blocks infection by multiple pathogens without causing toxicity.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Infectious DiseasePrimary Technology
Cell Biology
Drug Discovery
PharmacogenomicsClinical Development Stage
PreClinical

5AM Solutions
United States, http://www.5amsolutions.comCompany Classification
Associate/Service ProvidersOrganization Type
Consulting Firms

5AM Ventures
United States, http://www.5amventures.comCompany Classification
Associate/Service Providers

720 Strategies
United States, http://www.720strategies.com/Company Classification
Associate/Service ProvidersOrganization Type
Corporate Communication
Media

AAT Bioquest, Inc.
923 Thompson Place
Sunnyvale, CA, 94085
4087331055
http://www.aatbio.comPrimary Contacts
Jack Diwu
CEO
Jennifer Liao
VP
Cindy Zhang
VP
Company Profile
AAT Bioquest, Inc. (formerly ABD Bioquest, Inc.) develops, manufactures and markets bioanalytical research reagents and kits to scientists engaged in life sciences research, diagnostic R&D and drug discovery. We specialize in the area of photometric detections including absorption (color), fluorescence and luminescence technologies. The Company's products enable scientists and biomedical researchers to better understand biochemistry, immunology, cell biology and molecular biology. AAT Bioquest constantly introduces new products, and offers a rapidly expanding list of products that are grouped into several product lines. 1) Our reactive fluorescent and luminescent probes, biotins and tag enzymes are used for labeling small drug molecules and biopolymers, e.g, proteins, nucleic acids and carbohydrates; 2) We develop fluorescent and luminescent probes for detecting proteins, nucleic acids and live cells; 3) We constantly introduce novel fluorescent and luminescent probes for detecting various enzymes, in particular, hydrolytic and redox enzymes; 4) We focus on developing reagents for signal transduction research; and 5) We also offer physiological and neurological probes, e.g., calcium indicators and membrane potential probes. Besides the standard catalog products we also offer custom service to meet your special research needs. Our current services include custom synthesis of colorimetric, fluorescent and luminescent probes, custom development of biochemical, cell-based and diagnostic assays and custom screening of your compound libraries against your defined targets using our validated HTS assays.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioToolPrimary Technology
Cell Biology
Imaging
Screening

Abingworth Management Inc.
http://www.abingworth.comCompany Classification
Associate/Service ProvidersOrganization Type
Venture Capital

ACCELOVANCE, Inc.
2275 Research Blvd., Suite 700
Rockville, MD, 20850
619-446-8501
http://www.accelovance.comPrimary Contacts
Renee Hermer
Associate VP, Business Development
619.446.8501
Garrett D. Smith
VP, Business Development and Marketing
301-802-6275
Company Profile
Winner of the Vie Award for “BEST CRO” in 2009, 2010 and 2011, Accelovance has a proven approach for accelerating clinical development. Our ownership of a full-service CRO, research dedicated sites and strategic patient management solutions create operational efficiencies that enhance productivity, quality and timely delivery of clinical studies. Whether our services are used independently or as a fully outsourced solution, Sponsors benefit from our ability to leverage control at every level of the clinical process. 15-25% cost savings; 25-75% reduction in timelines; Guaranteed Deliverables.Company Classification
Associate/Service ProvidersOrganization Type
Contract Research OrganizationDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Cardiovascular & Circulatory Disorders
Central Nervous
Digestive System
Genetic Diseases
Infectious Disease
Kidneys & Genito-Urinary System
Metabolic/Endocrinology DisordersPrimary Technology
Drug Delivery
Drug Discovery
Gene/Cell TherapyClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Achaogen
7000 Shoreline Drive Ste 372
South San Francisco, CA, 94080
650.266.1120
http://www.achaogen.comPrimary Contacts
J. Kevin Judice, Ph.D.
Chief Executive Officer & Chief Scientific Officer
Kenneth J. Hillan, M.B. Ch.B.
Chief Medical Officer
John C. Doyle
Chief Operating Officer
Company Profile
Achaogen is a biopharmaceutical company dedicated to discovering and developing life-saving therapies that address the growing, significant unmet need of Gram-negative bacterial resistance.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Infectious DiseasePrimary Technology
Drug DiscoveryClinical Development Stage
PreClinical
Phase II

ACME Bioscience, Inc.
3941 E Bayshore Road
Palo Alto, CA, United States, 94303
(650) 969-8000
http://www.acmeca.comPrimary Contacts
Jason Zhang
President & CEO
ZJ Ni
Cheif Scientific Officer
Jane Wang
Vice President of Business Development
Company Profile
Acme Bioscience is a chemistry based contract research organization with its headquarter in Silicon Valley, and research labs both in Palo Alto and Shanghai Our business areas include: - Medicinal chemistry: lead optimization - Custom synthesis: reference compounds, intermediates, building blocks, by-products, drug metabolites etc. - Process research and development - New product developmentCompany Classification
Associate/Service ProvidersOrganization Type
Contract Research OrganizationDisease Areas of Focus
Cancer
Infectious DiseasePrimary Technology
Drug Discovery

ACT Biotech, Inc.
http://www.actbiotech.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

ActiveSite Pharmaceuticals, Inc.
1456 Fourth St., Unit C
Berkeley, CA, 94710
510-665-5939
http://www.activesitepharma.comPrimary Contacts
Sukanto Sinha
CEO
Tamie Chilcote
COO
Company Profile
ActiveSite Pharmaceuticals, Inc., is a privately held, preclinical stage pharmaceutical company, located in the San Francisco Bay Area. The company utilizes proprietary lead discovery technology to discover new inhibitors for therapeutic enzyme targets in diseases with unmet medical need.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Cardiovascular & Circulatory Disorders
Central Nervous
Genetic Diseases
Infectious Disease
Kidneys & Genito-Urinary System
Metabolic/Endocrinology Disorders
OphthalmologyPrimary Technology
Drug DiscoveryClinical Development Stage
PreClinical

Adheren
United States, http://www.adheren.com/Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

Aduro BioTech
626 Bancroft Way, 3C
Berkeley, CA, 94710-2224
510/848-4400 x101
http://www.adurobiotech.comPrimary Contacts
Stephen Isaacs
Chairman & CEO
Dirk Brockstedt
VP, Research & Developement
Company Profile
Aduro's therapeutic vaccines have already been tested in three Phase 1 clinical safety trials in cancer and infectious disease with a total of 30 patients, and Aduro is currently planning Phase 2A and Phase 1B cancer trials with its lead therapeutic, CRS-207. In addition to building its own proprietary pipeline, Aduro is actively seeking partnerships and contract research agreements to develop new vaccines and to boost the efficacies of other vaccines and treatments. Aduro can engineer a new vaccine strain and have it ready for clinical testing within 12 months.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
VaccineDisease Areas of Focus
Cancer
Infectious DiseaseClinical Development Stage
Phase II

Advansta Inc.
1455 Adams Dr. Suite 1160
Menlo Park, CA, United States, 94025
650-325-1982
http://www.advansta.comPrimary Contacts
Dmitry Bochkariov
President
Sia Ghazvini
Director, Business Development
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Analytics
BioToolPrimary Technology
Cell Biology
Drug Discovery
Proteomics

Advantage Pharma Solutions LLC
11379 Huntington Village Lane
Gold River, CA, United States, 95670
916-806-9377
Company Profile
Consulting company that focuses on Business Development and Supply Chain StrategiesCompany Classification
Associate/Service ProvidersOrganization Type
Consulting Firms
TherapeuticPrimary Technology
Biomanufacturing
Drug DeliveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Advantar Laboratories, Inc.
http://www.advantarlabs.comCompany Classification
Associate/Service Providers

Advocates-US LLC
10, S. Third Street, 3rd Floor
San Jose, CA, United States, 95113
001 (408) 3513386
http://www.advocates.ltd.ukPrimary Contacts
Jules Fisher
Managing Director
+44 (0)7885 574 573
Angelina Fisher
Director of Corporate Affairs
+44 (0)7959 671 290
Shona Moyes
Project Development Manager
+44 (0)131 661 6100
Company Profile
Advocates Pharmaceutical & Healthcare is a Contract Development Organisation. Since 2002, we have been committed to creating better opportunities for the development of drug therapies, treatments & investment into global drug development for the biotech, pharmaceutical & healthcare sector. Through our UK, US and Hong Kong operations, our scientists, project managers & technical experts progress compounds from lab bench to 1st in man (translational medicine) & from 1st in man to out-licensing point or commercialisation in the most cost effective & efficient way. By streamlining development programmes to global standards Advocates maximises the value of compounds & products, minimising time to market. This is one of our core strengths & where we add significant value. Discovery & Pre-Clinical Support Identification & lead optimisation Medical Devices Expertise CE marking & manufacturing Project Management & Controls Resource/budget planning Life-cycle management eCTD compliant project & document management system Supplies Management Vendor identification & selection Logistics management & technical assessment Pharmaceutical Development Technical support of formulation development Investigational Medicinal Product formulation & development management Operational CMC Manufacturing support & validation Technology scale-up & transfer Regulatory Preparation & Submission Common Technical Documentation & IMPD preparation Submissions to FDA, EMEA & national agencies Clinical identification/Good Laboratory Practices (cGLP) Quality & technical gap analysis Quality Auditing Good Manufacturing Practices (cGMP) & ISO compliance Qualified Person (QP) assessment Investor Support Technical due diligence & post-investment evaluationCompany Classification
Associate/Service ProvidersOrganization Type
Consulting Firms

Affymax, Inc.
4001 Miranda Avenue/ 4015 Miranda Avenue
Palo Alto, CA, 94304
(650) 812-8700
http://www.affymax.comPrimary Contacts
Sylvia Wheeler
Vice President, Corporate Communications
Company Profile
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax's product candidate, peginesatide, recently completed Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. For additional information, please visit www.affymax.com.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Blood & Lymphatic DiseasesClinical Development Stage
Phase III

Agilent Technologies, Inc.
5301 Stevens Creek Boulevard
Santa Clara, CA, 95051
408-345-8886
http://www.agilent.comPrimary Contacts
Bill Sullivan
President and CEO
Didier Hirsch
SVP and Chief Financial Officer
Nick Roelofs
President, Life Sciences Group
Company Profile
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioToolDisease Areas of Focus
Genetic Diseases
Infectious Disease
Metabolic/Endocrinology DisordersPrimary Technology
Bioinformatics
Drug Discovery
Functional Genetics
Genomics
Imaging
Micro Arrays
Nanotechnology
Proteomics

Alexander's Mobility Services
http://www.alexanders.netPrimary Contacts
Tina Reposa
800-654-6556
Company Profile
Alexander's is a private, woman-owned business providing comprehensive relocation, transportation and related mobility services to corporate clients around the globe. We were among the first in our industry to become ISO 9001: 2000 certified. Founded in 1953, Alexander's has nine operations across the United States and is strategically positioned to provide our superior services regard-less of where your company is coming from...or where it is going. For more information or to take advantage of this program contact Tina Reposa @ 800.654.6556 or email her at treposa@alexanders.net and let her know that you are a BayBio member.Company Classification
Associate/Service Providers

Alexza Pharmaceuticals, Inc.
2091 Stierlin Court
Mountain View, CA, United States, 94043
650.944.7000
http://www.alexza.comPrimary Contacts
Thomas B. King
President & CEO
August J. Moretti
SVP, CFO & General Counsel
James Cassella, PhD.
SVP, Research & Development
Company Profile
Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Medical DevicesDisease Areas of Focus
Central NervousPrimary Technology
Drug DeliveryClinical Development Stage
Phase III

Alion, Inc.
http://www.alionscience.com/Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

Alios BioPharma, Inc.
260 E. Grand Ave, 2nd Floor
South San Francisco, CA, 94080
650-635-5500
http://www.aliosbiopharma.comPrimary Contacts
Lawrence Blatt, Ph.D.
President & CEO
Leonid Beigelman, Ph.D.
CSO
Company Profile
Alios is a biotechnology company located in South San Francisco, California that is developing novel medicines that treat viral diseases. Alios has two platform technologies: small molecule activators of the RNase-L pathway and novel nucleoside/nucleotide chemistries. These complementary technologies have the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS). Alios has a staff of 28 full time employees, of which 22 are scientists, working in a 20,000 square foot facility. Alios management has discovered or led the development of numerous compounds that have reached the clinic for the treatment of chronic hepatitis C including: Infergen, Pegasys, RG7227, R1626, RG7128, and RG7348. We are funded by an experienced group of Venture Capital backers with extensive industry experience including: Novo A/S, Novartis Ventures, Roche Ventures, and SR-One (GlaxoSmithKline ventures).Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Infectious DiseasePrimary Technology
Drug DiscoveryClinical Development Stage
PreClinical

Allcells, LLC
http://allcells.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioTool

Allopartis
http://www.allopartis.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Industrial Biotechnology

AlloStem Therapeutics
920 Palo Alto Ave.
Palo Alto, CA, 94301-2223
650-814-6014
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

Alston & Bird LLP
275 Middlefield Road Suite 150
Menlo Park, CA, 94025
650-838-2000
http://www.alston.comPrimary Contacts
Romi Celli
Partner
650-838-2011
Joe Liebeschuetz
Partner
650-838-2000
Lance Termes
Senior Associate
650-838-2000
Company Profile
With 800 attorneys, Alston & Bird is a leading national AmLaw 100 firm. The firm’s core practice areas are intellectual property, complex litigation, corporate and tax, with national industry focuses in energy and sustainability, health care, financial services and public policy. The firm has built a reputation as one of the country’s best employers, appearing on FORTUNE magazine’s ranking of the “100 Best Companies to Work For” 12 consecutive years, an unprecedented accomplishment among law firms in the United States. The firm has offices in Atlanta, Charlotte, Dallas, Los Angeles, New York, Research Triangle, Silicon Valley, Ventura County and Washington, D.C. Our Silicon Valley office boasts extensive experience in biotechnology. Our Biotechnology Group provides a range of services including patentability, validity, non-infringement, and freedom-to-operate opinions, patent drafting, prosecution, due diligence analysis, development of business strategies, and general client counseling. All of the attorneys in our practice group have Ph.D.’s or master’s degrees representing diverse scientific fields. We service a wide range of corporate and university clients in the areas of molecular/cellular biology, genomics, pharmaceuticals, immunology, medical diagnostics, and agricultural biotechnology. Our corporate clients include leading biotechnology companies, large and mid-size pharmaceutical companies, and various smaller companies with cutting edge technologies.Company Classification
Associate/Service ProvidersOrganization Type
Law Firms

Alta Partners Management Corp.
One Embarcadero Center, Suite 3700
San Francisco, CA, United States, 94111
415-362-4022
http://www.altapartners.com/Primary Contacts
Georgianne Compton
Fund Accountant
415-362-4022
Company Classification
Associate/Service ProvidersOrganization Type
Venture Capital

Althea Technologies, Inc.
http://www.altheatech.comCompany Classification
Associate/Service ProvidersOrganization Type
Therapeutic

Altravax, Inc.
552 Del Rey Avenue
Sunnyvale, CA, 94085
(888)-710-9203
http://www.altravax.comPrimary Contacts
Richard Rayl
CEO
Robert Whalen
CSO
Company Profile
Altravax, Inc. is a privately held biopharmaceutical company with headquarters in Fargo, ND and research laboratories in Sunnyvale, CA. Altravax has acquired the rights to MolecularBreeding(TM) directed molecular evolution technology in the area of infectious diseases.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
VaccineDisease Areas of Focus
Infectious DiseasePrimary Technology
Combinatorial Chemistry
Protein EngineeringClinical Development Stage
PreClinical

Alvine Pharmaceuticals, Inc.
75 Shoreway Rd., Suite B
San Carlos, CA, 94070
650 632-1645
http://www.alvinepharma.comPrimary Contacts
Abhay Joshi, Ph.D.
President and Chief Executive Officer
Daniel Adelman, M.D.
Sr. VP of Development and Chief Medical Officer
Kirk Essemacher, M.D.
VP of Marketing, Corporate and Strategic Development
Company Profile
Alvine is a clinical stage biopharmaceutical company developing biologics to target autoimmune/inflammatory diseases.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Digestive SystemPrimary Technology
Drug DiscoveryClinical Development Stage
Phase II

Amarantus BioSciences
866 Malcolm Rd
Burlingame, CA, 94010
http://www.amarantus.comPrimary Contacts
Martin Cleary
CEO
Gerald Commissiong
COO
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Diagnostic
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Cardiovascular & Circulatory Disorders
Central Nervous
Metabolic/Endocrinology Disorders
Ophthalmology

Amunix, Inc.
500 Ellis St
Mountain View, CA, 94043
6504281800
http://www.amunix.comPrimary Contacts
Willem Stemmer
CEO
Volker Schellenberger
VP Research
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Cardiovascular & Circulatory DisordersPrimary Technology
Cell Biology
Protein EngineeringClinical Development Stage
PreClinical
Phase I

Amyris, Inc.
http://www.amyrisbiotech.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioFuels
Industrial Biotechnology

Aperys, Inc.
http://www.aperys.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioTool

Apexigen
http://www.apexigen.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

ApniCure, Inc.
900 Chesapeake Drive
Redwood City, CA, 94063
650-361-9300
http://www.apnicure.comPrimary Contacts
Matt Vaska
President & CEO
Chris Daniel
EVP, Operations
John Lipman
VP, Marketing
Company Profile
Developing novel therapy for sleep apnea.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Medical DevicesDisease Areas of Focus
Respiratory DisordersClinical Development Stage
Phase I

Applied Biomics, Inc.
23785 Cabot Blvd. Suite 311
Hayward, CA, 94545
510-887-0889
http://www.appliedbiomics.comPrimary Contacts
John Liao
CTO
Hongjin Huang
Vice President
Company Profile
Proteomics Service Proteomics Methods and Reagent DevelopmentCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
AnalyticsDisease Areas of Focus
CancerPrimary Technology
ProteomicsClinical Development Stage
PreClinical

Applied Stemcell, Inc.
http://www.appliedstemcell.comCompany Classification
Associate/Service Providers

APT Pharmaceuticals
700 Airport Blvd
Burlingame, CA, 94010
650-931-1666
http://www.aptbio.comPrimary Contacts
Stephen Dilly,MD.
CEO
Howard V Raff, Ph.D.
COO
Christina Thomson
General Council
Company Profile
Develop drugs to meet unmet medical needs in lung diseasesCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Respiratory DisordersPrimary Technology
Drug DeliveryClinical Development Stage
Phase III

Aradigm Corporation
United States, http://www.aradigm.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioTool

Aragen Bioscience
United States, http://www.aragenbio.com

Aratome, LLC
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioInformatics

Arcadia Biosciences, Inc.
202 Cousteau Place Ste 200
Davis, CA, 95168
(530) 756-7077
http://www.arcadiabio.comPrimary Contacts
Eric Rey
President and CEO
Wendy Neal
VP and Chief Legal Officer
Steve Brandwein
VP Finance
Company Profile
Agricultural products that benefit the environment or human health.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
AgricultureDisease Areas of Focus
Cardiovascular & Circulatory Disorders
Dermatology
Womens HealthPrimary Technology
Transgenics

Ardelyx, Inc. (formerly Nteryx, Inc)
34175 ARdenwood Blvd
Fremont, CA, 94555
510 745-1700
http://www.ardelyx.comPrimary Contacts
Michael G. Raab
CEO and Chairman
Dominique Charmot
Chief Scientific Officer
George Jue
Vice President Finance and Operations
Company Profile
Through a radical approach to drug discovery and development, Ardelyx™ has established a pipeline of novel, first-in-class drugs engineered to correct mineral metabolism imbalance and metabolic disorders.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Cardiovascular & Circulatory Disorders
Digestive System
Kidneys & Genito-Urinary System
Metabolic/Endocrinology DisordersPrimary Technology
Drug Discovery
GenomicsClinical Development Stage
PreClinical
Phase I
Phase II

Aria Diagnostics
5941 Optical Court, Suite 226
San Jose, CA, United States, 95138
(408) 960-2198
http://www.ariadx.comPrimary Contacts
John Stuelpnagel
Executive Chairman
Ken Song
CEO
Arnold Oliphant
CSO
Company Profile
Molecular diagnostics company focused on prenatal testing.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
DiagnosticPrimary Technology
Bioinformatics
GenomicsClinical Development Stage
PreClinical

Astraea Therapeutics, LLC
320 Logue Avenue, Suites 142/131
Mountain View, CA, 95070
650-254-0786
http://www.astraeatherapeutics.comPrimary Contacts
Nurulain Zaveri, Ph.D.
President and Chief Scientific Officer
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Cancer
Central Nervous
Substance AbusePrimary Technology
Combinatorial Chemistry
Drug Discovery

Athena Discovery Inc
http://www.athenadiscovery.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

Aurora Algae, Inc.
3325 Investment Blvd
Hayward, CA, 94545
5102665000
http://www.aurorainc.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioFuels

Auxogyn, Inc.
1490 Obrien Dr. Ste A
Menlo Park, CA, United States, 94025
650-931-6732
http://www.auxogyn.comPrimary Contacts
Rob Newman
Vice President, Regulatory Affairs
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Medical Devices

Avalanche Biotechnologies, Inc
665 Third St., Suite 250
San Francisco, CA, United States, 94107
650-924-1324
http://www.avalanchebiotech.comPrimary Contacts
Thomas Chalberg
Founder and CEO
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug Development
TherapeuticDisease Areas of Focus
OphthalmologyPrimary Technology
Gene/Cell TherapyClinical Development Stage
PreClinical
Phase I

AvidBiotics Corp.
300 Utah Ave., Suite 150
South San Francisco, CA, 94080
650.873.1141
http://www.avidbiotics.comPrimary Contacts
James L. Knighton
President
David W. Martin
CEO
Company Profile
AvidBiotics is a developer of novel, non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancers. The scaffolds of AvidBiotics' proteins exhibit functional potency, e.g. killing, exceeding that of antibodies. The company's lead program centers on Avidocin proteins, a new class of narrow-spectrum bactericidal agents for use in the treatment or prevention of specific bacterial infections. AvidBiotics is also developing novel Micacide proteins that specifically flag virus-infected or cancerous cells for enhanced destruction by the potent innate immunity system. AvidBiotics focuses on human therapeutic applications of its technologies, both on its own and in partnership with governmental agencies and research institutions, while taking advantage of further near-term collaborative opportunities offered by specific applications of its products and technology platforms in areas such as food safety, cleantech and biodefense.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Cancer
Infectious DiseasePrimary Technology
Drug Discovery
Protein EngineeringClinical Development Stage
PreClinical

Avrygen Therapeutics, Inc.
http://www.avrygen.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Therapeutic

BASi
2701 Kent Avenue
West Lafayette, IN, 47906
510 273 8889
http://www.basinc.comPrimary Contacts
Debra A. Gosling
Business Development Manager
510.582.1085
Mahnaz Shamsai
Business Development Manager
650.759.2783
Company Profile
BASi provides world-class research to the pharmaceutical industry worldwide. Established in 1974, we offer an extensive array of contract laboratory services including: Bioanalytical, Toxicology, Pharmaceutical Analysis, Stability, and Automated In Vivo PK/PD testing. In addition, manufacture more than 30-different scientific instruments, such as the Culex System for Automated Blood Sampling in tubes or Dried Blood Spots. At BASi we focus on developing innovative services and products that increase efficiency and reduce costs associated with taking new drugs to market.Company Classification
Associate/Service ProvidersOrganization Type
Contract Research Organization

Bay Area Biotechnologies
2324 Montpelier Dr. Ste 7
San Jose, CA, 95116
408-694-3573
http://www.bayareabiotechs.com/Primary Contacts
Devin Du
CEO & President
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioTool

Bay Area Biotechnology Education Consortium
P.O. Box 1824
Morgan Hill, CA, United States, 95038
408.924.4814
http://www.BABEC.orgPrimary Contacts
Katy Korsmeyer
President
408.924.4814
Victoria Walton
Treasurer
408.782.5037
Company Profile
The Bay Area Biotechnology Education Consortium (BABEC) is a regional network of local science education organizations based in the Northern California Bay Area. BABEC is dedicated to increasing student understanding of key concepts in molecular biology and raising student awareness of applications and careers in biotechnology. In the process, BABEC is enabling systemic reform in an important area of science education by helping teachers bring relevant, thought-provoking, hands-on activities into the classroom.Company Classification
Education, Research Institution, Government Agency, other Non-ProfitOrganization Type
Education

Bayhill Therapeutics, Inc.
1804 Embarcadero Rd. Suite 201
Palo Alto, CA, 94303
650-320-2800
http://www.bayhilltx.comPrimary Contacts
Hideki Garren
Executive VP / COO / CSO
Robert King
VP of Manufacturing
Joanne Quan
VP of Clinical and Regulatory
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Autoimmune & InflammatoryClinical Development Stage
PreClinical
Phase I
Phase II

BCC Partners
1215 Elder Avenue
Menlo Park, CA, 94025
650-323-1717
http://www.bccpartners.comPrimary Contacts
Karen L Bergman
Partner and Founder
650-323-1717
Michelle Corral
Partner and Founder
415-738-8383
Company Profile
Founded in 2001, BCC Partners, LLC provides outstanding strategic planning and execution of branding, competitive positioning, communications and investor relations services to public and private companies in the life sciences industry. With extensive experience from the corporate, agency, media and advocacy settings, we take a senior-level and hands-on approach to building distinctive positioning and visibility across targeted audiences in alignment with our clients' business objectives and values.Company Classification
Associate/Service ProvidersOrganization Type
Corporate Communication/Media

Bell Biosystems, Inc.
4305 El Camino Real
Palo Alto, CA, 94306
703-343-6477
http://www.bellbiosystems.comPrimary Contacts
Dr. Caleb B. Bell, III
CEO
Daniel Bell
CFO
Dr. Brett Staahl
CSO
Company Profile
Bell Biosystems' caters to researchers, institutions, academia, and private companies that develop stem cell diagnostics, cellular based therapeutics, and regenerative medicines.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Cancer
Cardiovascular & Circulatory DisordersPrimary Technology
Drug Delivery
Stem Cell ResearchClinical Development Stage
PreClinical

Bench International
120 South Doheny Drive
Beverly Hills, California, United States, 90211
310-854-9900
www.benchinternational.comPrimary Contacts
Denise DeMan
Founder, Chairman & CEO
310-854-9900
Jenny Breselow
Vice President
415-500-5748
Company Profile
We are a global, retained, executive recruiting and consulting firm providing senior talent to life science institutions, exclusively, since 1974. We pride ourselves as being one of the top executive recruitment providers for the Life Science including pharmaceutical, healthcare, biotech and other life sciences fields. Our team is deeply experienced and accomplished within the life sciences and has the content knowledge and expertise to translate and meet our client’s needs and expectations for executive talent. With headquarters in Los Angeles, California, and satellite offices in San Francisco, New York, the United Kingdom and Switzerland, Bench International’s multinational presence makes it one the largest retained executive search firms. The Bench International team comprises more than 30 seasoned executives with over 110 years of combined experience in life sciences recruiting.Company Classification
Associate/Service ProvidersOrganization Type
Consulting Firms
Human Resources
Staffing

Bend Research Inc.
64550 Research Rd.
Bend, Oregon, United States, 97701
541-382-4100
http://www.bendresearch.comPrimary Contacts
Walter Babcock
President and CEO
541-382-4100
Phoenex Ivers
Business Development Administrator
541-706-8326
Company Classification
Associate/Service ProvidersOrganization Type
Contract Research Organization

BetaStem Therapeutics
300 Brannan Street, Suite 407
San Francisco, CA, 94107
415-913-7595
http://betastemtherapy.com/Primary Contacts
Stephen Bartelmez PhD
President, CSO and Founder
Stephen Bartelmez PhD
CSO
Raj Prasad MBA
CFO
Company Profile
OVERVIEW: Patient-derived hematopoietic stem cells represent a proven clinical strategy for treatment of a wide range of important human diseases. BetaStem has developed proprietary methods and reagents to dramatically improve the application and efficacy of activated stem cell products from patient’s blood, bone marrow and cord blood. Applications for these products are broad and include unmet medical needs such as the repair of damaged blood vessels in heart disease, peripheral vascular disease and retinopathy, especially in the diabetic patient. Our stem cell approaches can also dramatically accelerate bone marrow stem cell engraftment in transplantation settings. BetaStem has developed an efficient pre-clinical development strategy that blends leading academic health care centers, substantial manufacturing and clinical outsourcing, with the goal of filing an IND by July 2011, and start a Phase 1 clinical trial by July 2012. PAIN: Therapies for diabetic retinopathy (a major cause of vision loss), coronary infarcts (heart attacks), and diabetic peripheral vascular disease are limited because they do not repair blood vessel endothelium. Our technology regenerates damaged endothelial cells which are a major component of blood vessels. In addition, our approaches can also improve current bone marrow transplantation processes that are used in the treatment of blood cancers. SOLUTION: Activate/enable a patient’s own stem cells to repair damaged vasculature by collecting stem cells from their blood and/or bone marrow, activating stem cells to overnight, and then administering the stem cells back to the patient for repair and regeneration (proliferation).Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
TherapeuticDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Metabolic/Endocrinology Disorders
OphthalmologyPrimary Technology
Cell Biology
Stem Cell ResearchClinical Development Stage
PreClinical

Bexel Pharmaceuticals Inc
32980 Alvarado-Niles Road Suite 810
Union City, CA, 94587
510-324-0015
http://www.orchidpharma.comPrimary Contacts
Dr. Prasad S Patala
Corporate Vice President
Aparna Mukherjee
Associate Manager- Scientific Affairs & Business Development
Company Profile
Bexel Pharmaceuticals Inc., an US subsidiary of Orchid Chemicals & Pharmaceuticals Ltd. Orchid Chemicals and Pharmaceuticals Ltd, India (ORCHID group) through its wholly owned subsidiaries, Orchid Research Laboratories Ltd in India, Bexel Pharmaceuticals Inc USA, and affiliate, Diakron Pharmaceuticals Inc in USA is an Integrated Research Company of Global Standing, is committed to the discovery and development of safe and efficacious medicines for global healthcare needs. Ongoing discovery and development programs are in the therapeutic areas of Cancer, Inflammation, Anti-infective, Cardio-Vascular and Metabolic Disorder. The key aspects include NCE/Product pipeline for licensing, flexible approach to collaboration, state-of-the-art research centers and access to the groups' Parent US FDA & MHRA approved Dosage and API facilities.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Autoimmune & Inflammatory
Cancer
Cardiovascular & Circulatory Disorders
Infectious Disease
Metabolic/Endocrinology DisordersPrimary Technology
Cell Biology
Combinatorial Chemistry
Drug DiscoveryClinical Development Stage
PreClinical
Phase I

Bio-Link
1855 Folsom Street, Suite 643
San Francisco, CA, United States, 94103
415 487 2470
http://www.bio-link.orgPrimary Contacts
Elaine A. Johnson, PhD
Executive Director
415-487-2472
Lisa Huffman
Office Manager and Events Coordinator
415-487-2471
Company Profile
Bio-Link is the Next Generation Advanced Technological Education (ATE) National Center of Excellence for Biotechnology and Life Sciences. Bio-Link has received major funding from the National Science Foundation to work with community and technical colleges that have programs that prepare the technical workforce for the biotechnology industry. Bio-Link is based at City College of San Francisco and serves to network biotechnology programs across the nation.Company Classification
Education, Research Institution, Government Agency, other Non-ProfitOrganization Type
EducationPrimary Technology
Bioinformatics
Biomanufacturing
Stem Cell Research

Bio-Rad Laboratories, Inc.
Alfred Nobel Drive
Hercules, CA, United States, 94547
510 724-7000
http://www.bio-rad.comPrimary Contacts
David Schwartz
Chairman of the Board
Norman Schwartz
President and CEO
Christine Tsingos
Vice President and CFO
Company Profile
Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative products and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,800 employees and serves more than 100,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
BioToolDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Genetic Diseases
Infectious Disease
Metabolic/Endocrinology DisordersPrimary Technology
Bioinformatics
Biomanufacturing
Cell Biology
Drug Discovery
Functional Genetics
Gene/Cell Therapy
Genomics
Imaging
Micro Arrays
Protein Engineering
Proteomics
Screening
Stem Cell Research

BioCardia
http://www.biocardia.comCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Medical Devices

BioCheck, Inc.
323 Vintage Park Drive
Foster City, CA, 94404
(650) 573-1968
http://www.biocheckinc.comPrimary Contacts
John Chen
CEO/President
Company Profile
BioCheck is a FDA and ISO certified facility specializing in the development, manufacturing and marketing of high-quality ELISA kits. Product line includes tests for tumor markers, cardiac markers, steroids, thyroids, TORCH and infectious diseases. BioCheck also provides contract services such as custom ELISA kit development, reagent manufacturing and antibody purification.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
DiagnosticDisease Areas of Focus
Cancer
Infectious Disease

Biologics Consulting Group, Inc.
1840 Gateway Drive, Suite 200
San Mateo, CA, 94404
650-378-1303
http://www.bcg-usa.com/index.htmlPrimary Contacts
Ronald A. Marchesani
Head, West Coast Operations
650-387-1303
Jim Kenimer
CEO/President
703-739-5695
Company Profile
Biologics Consulting Group, Inc. (BCG) is an international consulting firm whose consultants provide national and international regulatory and product development advice on the development and commercial production of biological, drug, and device products. Our staff consists of experts in regulatory affairs, product manufacturing and testing, pharmacology/toxicology, facility inspections, statistics, program management, and clinical trial design and evaluation. Many of our consultants are former CBER, CDER, and CDRH reviewers, certified FDA inspectors, and senior scientists from the biotechnology industry. Because of our familiarity with FDA expectations we have an excellent reputation at the Agency for filing high-quality, easily reviewable applicationsCompany Classification
Associate/Service ProvidersOrganization Type
Consulting FirmsDisease Areas of Focus
Autoimmune & Inflammatory
Blood & Lymphatic Diseases
Cancer
Central Nervous
Dental
Digestive System
Genetic Diseases
Infectious Disease
Kidneys & Genito-Urinary System
Metabolic/Endocrinology Disorders
Musculoskeletal Disorders
OphthalmologyPrimary Technology
Biomanufacturing
Gene/Cell Therapy
Stem Cell ResearchClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

BioMarin Pharmaceutical, Inc.
105 Digital Drive
Novato, CA, 94949
415-506-6700
http://www.bmrn.comPrimary Contacts
Jean-Jacques Bienaimè
Chief Executive Officer
Stephen Aselage
Executive Vice President, Business Operations
Henry J. Fuchs, M.D.
Executive Vice President and Chief Medical Officer
Company Profile
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four marketed products and multiple clinical and pre-clinical product candidates. Marketed products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (currently approved in the EU only) (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Drug DevelopmentDisease Areas of Focus
Cancer
Genetic Diseases
Metabolic/Endocrinology Disorders
Musculoskeletal DisordersPrimary Technology
Bioinformatics
Biomanufacturing
Drug DiscoveryClinical Development Stage
PreClinical
Phase I
Phase II
Phase III
Approved

Bioneer Inc.
1000 Atlantic Avenue
Alameda, CA, United States, 94501
(877) 264-4300
http://us.bioneer.com/Primary Contacts
Myeong Hee Kim
President
Vincent R. Prezioso, Ph.D.
Vice President of Sales and Marketing
Kira Reinhart
Director of Sales, North America
Company Profile
Bioneer Corporation is Korea's leading biotech company. Bioneer was the first Korean biotechnology company when it was established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet. Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems. After a successful Initial Public Offering a few years ago, Bioneer Corporation launched Bioneer Inc., a wholly owned subsidiary. The American subsidiary is located in a 22,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is devoted to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies. We have expertise in a wide range of areas. Our products include: - DNA amplification products - DNA purification products - RNA purification products - Phosphoramidites for DNA/RNA synthesis - Gene Synthesis services - Enzymes such as DNA polymerases and reverse transcriptase - DNA ladders and DNA markers - Oligonucleotide synthesis products - PCR master mixes - ExiPrep, automated Nucleic acid purification - ExiSpin, Combination Vortex/CentrifugeCompany Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Industrial BiotechnologyDisease Areas of Focus
Cancer
Cardiovascular & Circulatory Disorders
Genetic Diseases
Infectious Disease
Respiratory DisordersPrimary Technology
Drug Delivery
Functional Genetics
GenomicsClinical Development Stage
PreClinical

Bionovo, Inc.
5858 Horton St., Ste 400
Emeryville, CA, United States, 94608
510-601-2000
http://www.bionovo.comPrimary Contacts
Isaac Cohen
President & CEO
Tom Chesterman
Senior Vice President and Chief Financial Officer
Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Diagnostic

Biosearch Technologies, Inc.
81 Digital Drive
Novato, CA, 94949
415-883-8400
http://www.biosearchtech.comCompany Profile
Biosearch Technologies, Inc. is a privately held, ISO 9001:2008 certified company, located in northern California. Founded in 1993, Biosearch is a leader in the design, development and manufacture of sophisticated oligonucleotide-based tools. Products include fluorophores (CAL Fluor®, Quasar® and Pulsar® dyes) and dark quenchers (Black Hole Quencher® dyes) to be included in custom-synthesized probe formats for real-time, quantitative PCR and other genomic-based applications. In addition to basic R&D applications, Biosearch now leverages its demonstrated expertise in fully assembled RUO kits and the cGMP manufacture of oligonucleotide components for molecular diagnostic assays. Biosearch Technologies is registered with the FDA (registration number 3003009025), and as such, its contract manufacturing processes conform to all applicable GMP requirements per 21 CFR Part 820. Biosearch markets include pharmaceutical, in-vitro diagnostic, biotech, ag/bio, environmental and food testing, public health, and biodefense sectors.Company Classification
Bioscience/R&D/Non-Profit conducting R&DOrganization Type
Industrial BiotechnologyPrimary Technology
Genomics

BioStorage Technologies, Inc.
2910 Fortune Circle West, Suite E
Indianapolis, IN, 46241
1 866 697 2675
http://www.biostorage.comPrimary Contacts
Jessette Novero
Business Development Manager (Pacific Northwest)
650-731-3116
Nick Garside
Sr. Business Development Manager
317-332-5942
Company Profile
After years of working in pharmaceutical and biological development, the principals of BioStorage Technologies recognized the need to bring the science of development to sample storage and management. Because the industry had not yet developed the standards of Good Storage Practices, BioStorage Technologies took the rigorous scientific processes used in development and applied them to sample storage. With facilities custom-designed for cold chain management, BioStorage Technologies has definitively brought science to sample storage and protection.Company Classification
Associate/Service Providers